Tag: Hatch-Waxman
2
FebruaryPediatric Exclusivity: How the FDA Extends Market Protection Without Changing Patents
Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested pediatric studies. It doesn't extend patents but blocks generic approvals, creating a powerful regulatory tool that improves children's drug safety.
Recent posts
-
25 Jun 2026
Generic Drug Classifications: Types, Categories, and How They Work
-
31 Dec 2025
Vitamin K Foods on Warfarin: How to Eat Consistently for Stable Blood Thinning
-
15 Dec 2025
Sinusitis in Allergy Sufferers: Effective Treatment and When to See a Specialist
-
14 Oct 2025
Buy Cheap Generic Topamax Online - A Practical Guide
-
4 Jan 2026
How to Use Secure Messaging to Ask Medication Questions